Pharmacogenetics of Etanercept in Rheumatoid Arthritis
- 5 August 2008
- journal article
- review article
- Published by Informa UK Limited in Pharmacogenomics
- Vol. 9 (8), 1011-1015
- https://doi.org/10.2217/14622416.9.8.1011
Abstract
Etanercept is one of several TNF inhibitors approved for rheumatoid arthritis (RA) and a variety of other immune-mediated inflammatory conditions. Given the plethora of drugs approved for RA, and the wide variations in cost and treatment response, markers of efficacy would be very useful. Several candidate genes, including HLA-DRB1 alleles and those encoding TNF, TNF receptors and Fc receptors, have been examined for a role in the response to treatment with etanercept. In this review, we discuss pharmacogenetic studies of etanercept in RA and other diseases, and comment on the future of such analyses to advance the goal of personalized medicine in RA.Keywords
This publication has 22 references indexed in Scilit:
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- The HLA–DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixtureArthritis & Rheumatism, 2008
- Rheumatoid arthritis association at 6q23Nature Genetics, 2007
- TRAF1–C5as a Risk Locus for Rheumatoid Arthritis — A Genomewide StudyNew England Journal of Medicine, 2007
- Fcγ receptor type IIIA genotype and response to tumor necrosis factor α–blocking agents in patients with rheumatoid arthritisArthritis & Rheumatism, 2007
- Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2005
- The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanerceptArthritis & Rheumatism, 2004
- Genetic markers of treatment response in rheumatoid arthritisArthritis & Rheumatism, 2004
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987